Corporate News     15-Oct-20
AstraZeneca Pharma India to launch Calquence® in India
On 21 October 2020
AstraZeneca Pharma India will launch Calquence® ( Acalabrutinib 100mg capsules) in India on 21 October 2020.

Acalabrutinib100mg capsules (Calquence ®) is:
- indicated for the treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.
- indicated for treatment of patients with chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL).

Previous News
  Volumes spurt at SKF India Ltd counter
 ( Hot Pursuit - 24-Sep-24   11:00 )
  Volumes spurt at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 24-Sep-24   14:30 )
  Astrazeneca Pharma India Ltd leads gainers in 'A' group
 ( Hot Pursuit - 24-Sep-24   12:00 )
  AstraZeneca Pharma slumps after Q3 PAT slides 46% YoY to Rs 16 cr
 ( Hot Pursuit - 09-Feb-24   10:32 )
  Volumes spurt at Elgi Equipments Ltd counter
 ( Hot Pursuit - 05-Jul-22   14:30 )
  Astrazeneca Pharma India to hold board meeting
 ( Corporate News - 24-Jul-24   16:06 )
  HDFC Bank Ltd leads losers in 'A' group
 ( Hot Pursuit - 05-Jul-24   15:00 )
  Astrazeneca Pharma India announces board meeting date
 ( Corporate News - 02-Feb-22   11:28 )
  AstraZeneca Pharma hits 52 week high after Q1 PAT soars to Rs 54 cr
 ( Hot Pursuit - 14-Aug-23   16:04 )
  AstraZeneca Pharma receives DCGI approves to import pharmaceutical formulation for Dapagliflozin Tablets
 ( Corporate News - 24-Jul-23   18:05 )
  Astrazeneca Pharma India schedules board meeting
 ( Corporate News - 25-May-23   15:01 )
Other Stories
  State Bank of India receives affirmation in credit ratings from Moody's
  03-Oct-24   19:15
  Indian Oil signs B2B Framework Agreement with Nepal Oil Corporation
  03-Oct-24   19:06
  Mahindra & Mahindra's Thar ROXX records 1.76 lakh booking within 60 mins
  03-Oct-24   17:14
  Shilpa Medicare announces receipt of CEP from EDQM for API 'Desmopressin'
  03-Oct-24   17:12
  Board of Refex Industries approves fund raising up to Rs 927 cr via equity route
  03-Oct-24   17:05
  Mahindra & Mahindra Financial Services approves NCD issuance of Rs 750 cr
  03-Oct-24   17:02
  Rites signs MoU with Delhi Metro Rail Corporation
  03-Oct-24   16:42
  Scan Projects to convene board meeting
  03-Oct-24   15:58
  Polycab India to announce Quarterly Result
  03-Oct-24   15:58
  Hindustan Organic Chemicals to conduct board meeting
  03-Oct-24   15:58
Back Top